JP Morgan Chase’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-96,519
| Closed | -$6.96M | – | 6580 |
|
|
2020
Q4 | $6.96M | Sell |
96,519
-24,844
| -20% | -$1.3M | ﹤0.01% | 2516 |
|
|
2020
Q3 | $5.45M | Sell |
121,363
-139,626
| -53% | -$5.84M | ﹤0.01% | 2497 |
|
|
2020
Q2 | $11.8M | Sell |
260,989
-10,978
| -4% | -$492K | ﹤0.01% | 1763 |
|
|
2020
Q1 | $10.5M | Buy |
271,967
+52,743
| +24% | +$2.43M | ﹤0.01% | 1705 |
|
|
2019
Q4 | $10.1M | Sell |
219,224
-30,597
| -12% | -$1.32M | ﹤0.01% | 2101 |
|
|
2019
Q3 | $10.2M | Buy |
249,821
+10,110
| +4% | +$437K | ﹤0.01% | 2128 |
|
|
2019
Q2 | $11.5M | Buy |
239,711
+127,508
| +114% | +$6.7M | ﹤0.01% | 1992 |
|
|
2019
Q1 | $7.03M | Buy |
112,203
+8,277
| +8% | +$569K | ﹤0.01% | 2329 |
|
|
2018
Q4 | $6.21M | Buy |
103,926
+60,760
| +141% | +$3.65M | ﹤0.01% | 2403 |
|
|
2018
Q3 | $2.78M | Sell |
43,166
-15,680
| -27% | -$875K | ﹤0.01% | 3223 |
|
|
2018
Q2 | $2.65M | Sell |
58,846
-37,186
| -39% | -$1.48M | ﹤0.01% | 3184 |
|
|
2018
Q1 | $2.98M | Buy |
96,032
+67,002
| +231% | +$2.2M | ﹤0.01% | 2993 |
|
|
2017
Q4 | $868K | Buy |
29,030
+6,666
| +30% | +$193K | ﹤0.01% | 3799 |
|
|
2017
Q3 | $721K | Sell |
22,364
-37,227
| -62% | -$1.29M | ﹤0.01% | 3680 |
|
|
2017
Q2 | $1.99M | Sell |
59,591
-27,885
| -32% | -$832K | ﹤0.01% | 3047 |
|
|
2017
Q1 | $2.53M | Sell |
87,476
-53,762
| -38% | -$1.33M | ﹤0.01% | 2895 |
|
|
2016
Q4 | $3.16M | Buy |
141,238
+72,785
| +106% | +$1.42M | ﹤0.01% | 2791 |
|
|
2016
Q3 | $1.27M | Buy |
+68,453
| New | +$1.29M | ﹤0.01% | 3018 |
|
|
2015
Q3 | – | Sell |
-241,600
| Closed | -$2.28M | – | 4314 |
|
|
2015
Q2 | $2.28M | Sell |
241,600
-17,900
| -7% | -$166K | ﹤0.01% | 2837 |
|
|
2015
Q1 | $2.3M | Buy |
+259,500
| New | +$2.62M | ﹤0.01% | 2803 |
|
|
2014
Q3 | – | Sell |
-49,796
| Closed | -$357K | – | 4401 |
|
|
2014
Q2 | $357K | Buy |
49,796
+4,397
| +10% | +$35K | ﹤0.01% | 3226 |
|
|
2014
Q1 | $458K | Buy |
45,399
+34,322
| +310% | +$316K | ﹤0.01% | 3163 |
|
|
2013
Q4 | $88K | Buy |
+11,077
| New | +$103K | ﹤0.01% | 3923 |
|
Other funds holding BEAT
JP Morgan Chase's BEAT Position: Q1 2021 in Review
JP Morgan Chase sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 96,519 shares — an estimated $6.96M sold.
JP Morgan Chase first reported a position in BEAT in Q4 2013 and held it in 23 quarters. The position peaked at $11.8M in Q2 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- JP Morgan Chase reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- JP Morgan Chase sold 96,519 BioTelemetry, Inc. shares in Q1 2021, an estimated $6.96M.
- JP Morgan Chase first reported a position in BioTelemetry, Inc. in Q4 2013 and held it in 23 quarters.
- JP Morgan Chase's BioTelemetry, Inc. position peaked at $11.8M in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.